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Background: Paraganglioma of the urinary bladder is a rare tumor. Herein we sought to describe a case of locally
advanced paraganglioma of the urinary bladder managed by partial cystectomy and extended pelvic lymph node
dissection.
Case presentation: The case of a 43-year old Haitian male with locally advanced paraganglioma of the urinary bladder
is presented in detail. Through surgical extirpation, our patient was rendered disease-free. Eighteen months later the
patient is doing well without symptoms but is noted to have subcentimeter bilateral pulmonary nodules and
retroperitoneal lymph nodes. No further therapy has been initiated at this time.
Conclusions: Patients with localized tumors have an extremely favorable prognosis and may be managed by less
aggressive modalities, whereas patients with metastatic disease have a significant reduced survival rate despite aggressive
treatment.
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Paraganglioma of the urinary bladder is a rare tumor that
originates from chromaffin tissue of the sympathetic ner-
vous system associated with the urinary bladder wall.
These tumors of the sympathetic nervous tissue may be
non-functional or functional, i.e., secrete catecholamine
causing paroxysmal hypertension, palpitation, and mictur-
ition syncope [1]. Typically these tumors possess the cap-
acity to invade and thus are deemed malignant, yet lack
mitoses and cellular dissociation that are usually associ-
ated with malignant tumors [2]. Numerous, small series
case reports have been published in the English literature
since it was first reported in 1953 by Zimmerman et al.
[3]. Herein we sought to describe a case of locally ad-
vanced paraganglioma of the urinary bladder treated by
partial cystectomy and extended lymph node dissection.
Paraganglioma (aka pheochromocytomas) of the urinary
bladder are exceedingly rare tumors accounting for less
than 0.05% of all bladder tumors and less than 1% of all
pheochromocytomas. In the genitourinary tract, the urinary* Correspondence: charles.rosser@orlandohealth.com
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reproduction in any medium, provided the orbladder is the most common site for paragangliomas
(79.2%), followed by the urethra (12.7%), pelvis (4.9%), and
ureter (3.2%) [4,5]. Furthermore, approximately 10% of all
extra adrenal pheochromocytomas are malignant [5]. Sev-
eral reviews have been written on paragangliomas of the
urinary bladder [6,7].
Symptoms reported in the current literature range from
the typical micturition attacks of headache and palpitations
to more abstract signs such as paraesthesias and dyspnea.
While our patient lacked some of the more common pre-
senting symptoms of bladder paraganglioma, e.g., hyper-
tension, he did have hematuria and lower urinary tract
symptoms, testifying to the variability in which this disease
can present itself. Furthermore, the consequences of hyper-
tension itself may muddle the initial diagnostic picture of
these patients. Patients often seek medical attention only
when their hypertension has become so advanced as to
cause syncope, retinopathy, or intracranial hemorrhage [8].
Physicians must constantly be wary of an undiagnosed
paraganglioma in the setting of unexplained hypertension
or associated symptoms.
Reported treatment options for localized or locally ad-
vanced paraganglioma of the urinary bladder include radical
cystectomy, partial cystectomy and transurethral resection.
Approximately 3% of patients with reported follow-up diedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and













Figure 1 Contrasted enhanced CT axial images of the pelvis. (A) Initial bladder tumor measuring 3.7 cm by 1.8 cm, (B) enlarged right pelvic
lymph node (other cuts demonstrated bulky bilateral pelvic adenopathy), (C) post-operative imaging (12 months) no bladder tumor evident and
(D) post-operative imaging (12 months) no pathologic pelvic adenopathy.
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be achieved with the above therapies. It is important to
note, however, that over 20% of patients did have recur-
rence or metastases at the last known follow-up [6,7]. In
the face of metastatic paraganglioma, surgical treatment is
rarely curative. It may adequately prolong survival by redu-
cing comorbid conditions (i.e. hypertension) and reducing
tumor burden, but adjunct therapies are usually indicatedA B
ED
Figure 2 Paraganglioma of the urinary bladder is shown. (A) H&E of tu
tumor from partial cystectomy specimen (200× magnification), (C) H&E of m
magnification), (D) Chromogranin IHC (40× magnification), (E) synaptophys[8]. Thus patients should be counseled according to their
individual presentation and disease status.
Case presentation
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. After MD Anderson Cancer Center Orlando insti-
tutional review board approval, the clinical and hospitalC
F
mor from partial cystectomy specimen (40× magnification), (B) H&E of
etastatic tumor from one of 13 positive lymph nodes (40×
in IHC (40× magnification) and (F) CD56 IHC (40× magnification).
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presented to our outpatient clinic in February 2011 were
reviewed for demographics, clinical and pathologic infor-
mation as well as outcome.
A 43-year old Haitian male presented to an outside ur-
ologist for intermittent painless gross hematuria for the
past six months. The patient reported some mild urinary
symptoms (frequency, intermittency, and nocturia times
three, AUA symptom score of 8). He denied a history of
headaches, blurry vision, or other symptoms associated
with micturition such as palpitations or dizziness. No ab-
normalities were noted on physical examination. The pa-
tient underwent a computed tomography of the chest,
abdomen and pelvis without and with intravenous con-
trast that demonstrated a 3.7 cm by 1.8 cm mass on the
anterior/superior aspect of the bladder associated with
bulky bilateral pelvic adenopathy (Figure 1). Urinary
normetanephrine was elevated at 5412 μg/24 hr. The pa-
tient was taken to the operating room in February of 2011
where the bladder tumor was biopsied and found to be a
paraganglioma. He was then referred to MD Anderson
Cancer Center Orlando for further management. The pa-
tient was evaluated by both Urologic Oncology and Med-
ical Oncology, who confirmed the above information. The
patient was not hypertensive; his physical exam remained
normal. In addition, serum creatinine, alkaline phosphat-
ase and hemoglobin were noted to be 0.9 mg/dL, 96 IU/L
and 12.4 g/dL, respectively. Urinary dipstick was negative.
The patient was placed on Diltiazem extended release
180 mg orally once a day. At the end of February, the pa-
tient was taken back to the operating room for a trans-
urethral resection of the bladder tumor and random
bladder biopsies. The entire tumor was visible was
resected. Exam under anesthetic did not demonstrate a
palpable mass or bladder pedicle thickening. Pathology
demonstrated paraganglioma confirmed with positive im-
munohistochemical stains for both synaptophysin and
chromagranin. Random bladder biopsies and prostatic ur-
ethral biopsy were negative for malignancy.
Approximately one month later, the patient underwent
a partial cystectomy and extended bilateral pelvic lymph
node dissection. Intraoperative frozen sections of the
urinary bladder demonstrated negative surgical margins.
The patient had an unremarkable immediate post-
operative course and was discharge to home on post-
operative day 6 with a urinary catheter in place. One
week later the urinary catheter was removed. Final path-
ology demonstrated invasive paraganglioma 2.7 cm in
maximum dimension. Final surgical margins are nega-
tive. The tumor cells are diffusely and strongly positive
for CD56, Chromagranin A, and synaptophysin, but are
negative for cytokeratin 7, cytokeratin 20, cytokeratin
AE1/3, and S-100. Twenty-three lymph nodes removed
with 13 of the nodes involved with metastatic disease.Pathologic imaging is illustrated in Figure 2. H&E stain-
ing of primary tumor notes typical zellballen growth pat-
tern of tumor. Eighteen months later the patient is
doing well without symptoms but is noted to have
subcentimeter bilateral pulmonary nodules and retro-
peritoneal lymph nodes. No further therapy has been
initiated at this time.Conclusion
In summary, paragangliomas of the urinary bladder tend
to be functional. Initial presentation is extremely varied
in these cancers, necessitating a low threshold of suspi-
cion in the face of hypertension or hematuria. Patients
with localized tumors have a favorable prognosis and may
be managed by less radical modalities, whereas patients
with metastatic disease have a significantly reduced
survival rate. Moving forward, it would be helpful to
standardize the reporting guidelines of paragangliomas
cases to better understand the natural process and
outcomes.
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